Authors: KNOOP A ANDREASEN PA ANDERSEN JA HANSEN S LAENKHOLM AV SIMONSEN ACW ANDERSEN J OVERGAARD J ROSE C

Citation: A. Knoop et al., PROGNOSTIC-SIGNIFICANCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PRIMARY BREAST-CANCER, British Journal of Cancer, 77(6), 1998, pp. 932-940

Authors: CHRISTENSEN L SIMONSEN ACW HEEGAARD CW MOESTRUP SK ANDERSEN JA ANDREASEN PA

Citation: L. Christensen et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR, UROKINASE RECEPTOR AND ALPHA(2)-MACROGLOBULIN RECEPTOR IN HUMAN BREAST CARCINOMAS, International journal of cancer, 66(4), 1996, pp. 441-452

Authors: KJOLLER L SIMONSEN ACW ELLGAARD L ANDREASEN PA

Citation: L. Kjoller et al., DIFFERENTIAL REGULATION OF UROKINASE-TYPE-1 INHIBITOR COMPLEX ENDOCYTOSIS BY PHORBOL ESTERS IN DIFFERENT CELL-LINES IS ASSOCIATED WITH DIFFERENTIAL REGULATION OF ALPHA(2)-MACROGLOBULIN RECEPTOR AND UROKINASE RECEPTOR EXPRESSION, Molecular and cellular endocrinology, 109(2), 1995, pp. 209-217

Authors: HEEGAARD CW SIMONSEN ACW OKA K KJOLLER L CHRISTENSEN A MADSEN B ELLGAARD L CHAN L ANDREASEN PA

Citation: Cw. Heegaard et al., VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR BINDS AND MEDIATES ENDOCYTOSIS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR-TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR COMPLEX, The Journal of biological chemistry, 270(35), 1995, pp. 20855-20861

Authors: SIMONSEN ACW HEEGAARD CW RASMUSSEN LK ELLGAARD L KJOLLER L CHRISTENSEN A ETZERODT M ANDREASEN PA

Citation: Acw. Simonsen et al., VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR FROM MAMMARY-GLAND AND MAMMARY EPITHELIAL-CELL LINES BINDS AND MEDIATES ENDOCYTOSIS OF M(R)-40,000 RECEPTOR-ASSOCIATED PROTEIN, FEBS letters, 354(3), 1994, pp. 279-283